Steady-state pharmacokinetics of a novel extended-release metformin formulation

Clinical Pharmacokinetics

Volumn 44, Issue 7, 2005, Pages 721-729

  Timmins, Peter ^a   Donahue, Steve ^a   Meeker, Jeff ^a   Marathe, Punit ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN;

ABDOMINAL PAIN; ADULT; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROLYTE DISTURBANCE; ENDOCRINE DISEASE; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEADACHE; HEARTBURN; HEMATOLOGIC DISEASE; HUMAN; KIDNEY DISEASE; MALE; METABOLIC DISORDER; MUSCLE CRAMP; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SINGLE DRUG DOSE; SKIN DISEASE; STEADY STATE; UROGENITAL TRACT DISEASE; VISUAL IMPAIRMENT;

ADMINISTRATION, ORAL; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL DISEASES; HALF-LIFE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; TABLETS; TIME FACTORS;

EID: 22244470759     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200544070-00004     Document Type: Article

References (21)

1. Vidon N, Chaussade S, Noel M, et al. Metformin in the digestive tract. Diabetes Res Clin Pract 1988; 4: 223-9
2. Tucker GT, Casey C, Phillips PJ, et al. Metformin kinetics in healthy subjects and in patients with diabetes mellitus. J Clin Pharmacol 1981; 12: 235-46
3. Sambol NC, Chiang J, O'Conner M, et al. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin dependent diabetes mellitus. J Clin Pharmacol 1996; 36: 1012-21
4. Sambol NC, Brookes LG, Chiang J, et al. Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man. Br J Clin Pharmacol 1996; 42: 510-2
5. Bretnall AE, Clarke GS. Metformin hydrochloride. In: Brittain HG, editor. Analytical profiles of drug substances and excipi-ents. Vol. 25. San Diego (CA): Academic Press, 1998: 243-93
6. Marathe PH, Wen Y, Norton J, et al. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br J Clin Pharmacol 2000; 50: 325-32
7. Timmins P, Dennis AB, Vyas KA, inventors. Bristol-Myers Squibb Company, assignee. Biphasic controlled release delivery system for high solubility pharmaceuticals and method. US patent 6,475,521. 2002 Nov 5
8. Caldwell LJ, Gardener CR, Cargill RC, inventors. Merck and Co, Inc, assignee. Drug delivery device which can be retained in the stomach for a controlled period of time. US patent 4,767,627. 1988 Aug 30
9. Urquart J, Theeuwes F, inventors. Alza Corporation, assignee. Drug delivery system comprising a reservoir containing a plurality of tiny pills. US patent 4,434,153. 1984 Feb 28
10. Shell JW, inventor. DepoMed Systems, Inc, assignee. Sustained-release oral drug dosage form. US Patent 5,007,790. 1991 Apr 16
11. Shell JW, inventor. DepoMed Systems, Inc, assignee. Alkylsubstituted cellulose-based sustained-release oral drug dosage forms. World patent WO 9318755. 1993 Sep 30
12. Shell JW, inventor. DepoMed Sytems, Inc, assignee. Alkyl-substituted cellulose-based sustained-release oral drug dosage forms. US patent 5,582,837. 1996 Dec 10
13. Hebden JM, Gilchrist PJ, Blackshaw E, et al. Night-time quiescence and morning activation in the human colon: effect on transit of dispersed and large single unit formulations. Eur J Gastroenterol Hepatol 1999; 11: 1379-85
14. Glucophage (metformin hydrochloride) and glucophage XR (metformin hydrochloride extended-release tablets) prescribing information. Princeton (NJ): Bristol-Myers Squibb Company, 2002
15. Data on file, Bristol-Myers Squibb Company, 1998
16. Di Colo G, Falchi S, Zambito Y. In vitro evaluation of a system for Ph-controlled peroral delivery of metformin. J Control Release 2002; 80: 119-28
17. Yuen KH, Peh KK, Tan BL. Relating in vitro/in vivo data of two controlled-release metformin formulations. Drug Dev Ind Pharm 1999; 25: 613-8
18. Pentikainen PJ. Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained-release products. Int J Clin Pharmacol Ther Toxicol 1986; 24: 213-20
19. Noel DS. Kinetic study of normal and sustained release dosage forms of metformin in normal subjects. J Int Biomed Inform Data 1980; 1: 9-20
20. Karttunen P, Uusitupa M, Lamminsivu U. The pharmacokinetics of metformin: a comparison of the properties of a rapid-release and a sustained-release preparation. Int J Clin Pharmacol Ther Toxicol 1983; 21: 31-6
21. Gusler G, Gorsline J, Levy G, et al. Pharmacokinetics of a metformin gastro-retentive tablets in healthy volunteers. J Clin Pharmacol 2001; 41: 655-61